Company
Headquarters: Bergen, Norway
kr348.8 Million
NOK as of July 1, 2024
US$32.7 Million
| Company | Market Cap (USD) |
|---|---|
| Abbott | $233.33 B |
| Boston Scientific Corporation | $154.34 B |
| Stryker | $151.06 B |
| Medtronic | $113.25 B |
| Edwards Lifesciences Corporation | $45.05 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $699.59 B |
| Johnson & Johnson | $374.29 B |
| AbbVie | $336.94 B |
| Novo Nordisk | $309.91 B |
| UnitedHealth Group | $279.90 B |
Lifecare AS engages in the research and development of medical sensors for health monitoring in Norway. It develops Sencell, a long term implantable micro sensor for monitoring glucose levels. The company was founded in 2006 and is headquartered in Bergen, Norway.
Lifecare AS has the following listings and related stock indices.
Stock: OSE: LIFE wb_incandescent